Kestra Medical Technologies Stock EBITDA
| KMTS Stock | 26.65 0.04 0.15% |
Fundamental analysis of Kestra Medical allows traders to better anticipate movements in Kestra Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
| Last Reported | Projected for Next Year | ||
| EBITDA | -88.2 M | -92.6 M |
Kestra | EBITDA | Build AI portfolio with Kestra Stock |
Kestra Medical Technologies Company EBITDA Analysis
Kestra Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Kestra Medical EBITDA | (97.98 M) |
Most of Kestra Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kestra Medical Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Kestra EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Kestra Medical is extremely important. It helps to project a fair market value of Kestra Stock properly, considering its historical fundamentals such as EBITDA. Since Kestra Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Kestra Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Kestra Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Kestra Ebitda
Ebitda |
|
According to the company disclosure, Kestra Medical Technologies reported earnings before interest,tax, depreciation and amortization of (97.98 Million). This is 111.17% lower than that of the Health Care Equipment & Supplies sector and 120.83% lower than that of the Health Care industry. The ebitda for all United States stocks is 102.51% higher than that of the company.
Kestra EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kestra Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kestra Medical could also be used in its relative valuation, which is a method of valuing Kestra Medical by comparing valuation metrics of similar companies.Kestra Medical is currently under evaluation in ebitda category among its peers.
Kestra Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Kestra Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Kestra Medical's managers, analysts, and investors.Environmental | Governance | Social |
Kestra Fundamentals
| Return On Equity | -1.26 | ||||
| Return On Asset | -0.44 | ||||
| Profit Margin | (1.78) % | ||||
| Operating Margin | (1.41) % | ||||
| Current Valuation | 1.36 B | ||||
| Shares Outstanding | 58.35 M | ||||
| Shares Owned By Insiders | 5.52 % | ||||
| Shares Owned By Institutions | 84.65 % | ||||
| Number Of Shares Shorted | 1.99 M | ||||
| Price To Book | 9.09 X | ||||
| Price To Sales | 20.07 X | ||||
| Revenue | 59.81 M | ||||
| Gross Profit | 34.46 M | ||||
| EBITDA | (97.98 M) | ||||
| Net Income | (113.81 M) | ||||
| Total Debt | 44.31 M | ||||
| Book Value Per Share | 3.19 X | ||||
| Cash Flow From Operations | (77.61 M) | ||||
| Short Ratio | 4.98 X | ||||
| Earnings Per Share | (3.96) X | ||||
| Target Price | 29.14 | ||||
| Number Of Employees | 330 | ||||
| Market Capitalization | 1.49 B | ||||
| Total Asset | 295.74 M | ||||
| Retained Earnings | (520.25 M) | ||||
| Working Capital | 217.35 M | ||||
| Net Asset | 295.74 M |
About Kestra Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kestra Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kestra Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kestra Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Kestra Stock Analysis
When running Kestra Medical's price analysis, check to measure Kestra Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kestra Medical is operating at the current time. Most of Kestra Medical's value examination focuses on studying past and present price action to predict the probability of Kestra Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kestra Medical's price. Additionally, you may evaluate how the addition of Kestra Medical to your portfolios can decrease your overall portfolio volatility.